The transactions outlined below are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. The obligation of Hazel to enter into definitive documents is subject to the satisfaction of various conditions precedent, at the sole discretion of Hazel, including, but not limited to, satisfactory finalization of due diligence and all required internal approvals, receipt of certain third-party consents required, and finalization of documentation. Consummation of the transactions contemplated by the Term Sheet are also subject to additional fundings by other parties and certain debt concessions by other stakeholders. As a result, there can be no guarantee that the transactions contemplated by the Term Sheet will be consummated.
Transactions Overview
In collaboration with Hazel and Virage, MSP Recovery has agreed to initiate a comprehensive corporate restructuring and funding plan designed to reinforce its financial stability, support operational growth, and streamline recovery servicing. Key components of the contemplated restructuring include:
Operational Funding to New ServicerHazel would provide up to $25 million in operational funding through a structured facility to the New Servicer, funded in tranches of up to $1.75 million per month, subject to meeting certain milestones beginning on September 2025, with a maturity date of June 30, 2027. This funding would create a new servicer subsidiary of MSP Recovery (the "New Servicer") on a go forward basis and will support the buildout of a dedicated team to provide technology-enabled recovery services for Medicare Secondary Payer (MSP) claims and similar matters. The New Servicer's directors and management team would be independent from the Company and outside of its control. The team would manage a scalable servicing platform built on MSP Recovery's proprietary data systems.
Operational ...